Experimental Cord Blood Treatments for Diseases
These are diseases for which Stem Cell treatments have not been proven to have any efficacy in human beings. In a “Phase I” clinical trial, the purpose of the study is to find out if the therapy makes any difference in the course of the disease, as compared to a control group. Some doctors may also be giving Stem Cells to patients in experiments outside of clinical trials, but in the United States such experiments are subject to limitations imposed by FDA regulations. This category also covers experiments in the laboratory, either with cell cultures or animals.
Auto-Immune diseases
- Arthritis, Juvenile
- Arthritis, Rheumatoid
- Crohn’s Disease
- Evan Syndrome
- Juvenile Dermatomyositis
- Scleroderma
Gene Therapy (ie: Transplanting genetically altered Stem Cells)
- Fanconi’s Anemia
- Metabolic Disorders (Leukodystrophy diseases, Storage Disorders, etc.)
- Parkinson’s Disease
Nerve cell repair diseases of the Central Nervous System
- Amyotrophic Lateral Sclerosis (ALS, or “Lou Gehrig’s disease”)
- Alzheimer’s Disease
- Huntington’s Disease
- Parkinson’s Disease
- Traumatic injury
- Spinal cord injury
- Stroke recovery
Organ repair
Kidney
- Combined transplant of kidney plus hematopoietic Stem Cells
- Growth of renal cells from adult Stem Cells
Liver
Lungs
Bookmark at:StumbleUpon | Digg | Del.icio.us | Dzone | Newsvine | Spurl | Reddit | Yahoo! MyWeb
Email This Article to Friends & Family
